IP Library Granted Patent US 11,129,799
Granted Patent B2
US 11,129,799 · App. 13/084,681 · Granted Sep 28, 2021

Dual lane coating

Inventor: Beuford A. Bogue (New Carlisle, IN)
Assignee: Aquestive Therapeutics, Inc.
A61K9/7007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,129,799
App. No.
13/084,681
Granted
Sep 28, 2021
Kind
B2
Abstract

The present invention relates to methods and apparatuses for forming an active-containing film product, while significantly reducing the amount of wasted active material. The resulting product is an active-containing film product that meets the user's predetermined criteria of physical properties and is suitable for use.

Claims (24)

1. A method of forming an active component-containing film product in a film forming apparatus, comprising the steps of:

a. providing a coating head configured to deposit a film forming matrix in a first lane and in a second lane onto a substrate, wherein said first lane and said second lane are offset from and substantially parallel to one another;

b. providing a first batch of a first film forming matrix comprising at least one polymer;

c. providing a second batch of a second film forming matrix comprising at least one polymer and an active component;

d. applying a layer of said first batch through said coating head in said first lane and drying said first applied layer to form a resulting surrogate film;

e. measuring said resulting surrogate film for at least one physical property;

f. optionally, adjusting at least one processing parameter and repeating steps (d) and (e) above to modify said at least one physical property; and thereafter

g. applying a layer of said second batch in said second lane and drying said second applied layer to form the active component-containing film product,

wherein said active component is selected from the group consisting of pharmaceuticals, pharmaceutically active agents, medicaments, drugs, neutraceuticals, cosmetic agents, biologic agents, bioeffecting substances, medicating active ingredients, medications, and combinations thereof; and wherein said surrogate film comprises less active component than said active component-containing film product or comprises no active component.

2. The method of claim 1 , wherein each of said lanes comprises two parallel dams forming the sides of said lane.

3. The method of claim 1 , wherein said coating head comprises at least three lanes.

4. The method of claim 1 , wherein said lanes each have width of about 20 to about 40 mm.

5. The method of claim 1 , wherein said first film forming matrix includes a polymer, a solvent, and no active.

6. The method of claim 1 , wherein said second film forming matrix includes a polymer, a solvent and an active.

7. The method of claim 1 , wherein said film forming apparatus comprises a coating roller, a movable substrate, and a drying apparatus.

8. The method of claim 7 , wherein step (d) comprises the step of moving said substrate through said drying apparatus.

9. The method of claim 1 , wherein said physical property includes at least one physical property selected from group consisting of film thickness, moisture content, coat weight, and combinations thereof.

10. The method of claim 1 , wherein said physical property includes visible defects.

11. The method of claim 1 , wherein said processing parameter comprises a parameter selected from the group consisting of roller gap size, substrate speed, drying temperature, and combinations thereof.

12. The method of claim 1 , wherein said second batch includes at least 30% active by weight based on the weight of the second batch.

13. The method of claim 1 , wherein said second batch is applied to said substrate at about 10 mg/cm 2 .

14. The method of claim 1 , further comprising the step of:

h. cutting said film product into a plurality of individual dosage units of the same size.

15. The method of claim 14 , wherein assays of said individual dosage units have a relative standard deviation not greater than 7.8%.

Assignments (12)
RELEASE OF SECURITY INTEREST Recorded May 13, 2026
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: AQUESTIVE THERAPEUTICS, INC.
Reel/Frame 075646/0258 →
SECURITY INTEREST Recorded May 12, 2026
From: AQUESTIVE THERAPEUTICS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 075561/0782 →
SECURITY INTEREST Recorded Nov 2, 2023
From: AQUESTIVE THERAPEUTICS, INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 065446/0494 →
RELEASE OF SECURITY INTEREST Recorded Nov 1, 2023
From: U.S. BANK TRUST COMPANY NATIONAL ASSOCIATION (AS SUCCESSOR IN INTEREST TO U.S BANK NATIONAL ASSOCIATION)
To: AQUESTIVE THERAPEUTICS, INC.
Reel/Frame 065426/0642 →
RELEASE OF SECURITY INTEREST Recorded Jul 15, 2019
From: PERCEPTIVE CREDIT HOLDINGS, LP
To: AQUESTIVE THERAPEUTICS, INC.; MONOSOL RX, INC.; MSRX US, LLC
Reel/Frame 049757/0733 →
SECURITY INTEREST Recorded Jul 15, 2019
From: AQUESTIVE THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 049758/0082 →
AMENDMENT TO PATENT SECURITY AGREEMENT RECORDED AT REEL/FRAME 039707/0194 Recorded Jan 30, 2018
From: AQUESTIVE THERAPEUTICS, INC.
To: PERCEPTIVE CREDIT HOLDINGS, LP
Reel/Frame 045279/0802 →
CHANGE OF NAME Recorded Jan 29, 2018
From: MONOSOL RX, LLC
To: AQUESTIVE THERAPEUTICS, INC.
Reel/Frame 045196/0389 →
RELEASE OF SECURITY INTEREST Recorded Aug 22, 2016
From: WHITE OAK GLOBAL ADVISORS, LLC
To: MONOSOL RX, LLC
Reel/Frame 039774/0782 →
SECURITY INTEREST Recorded Aug 16, 2016
From: MONOSOL RX, LLC; MONOSOL RX, INC.; MSRX US, LLC
To: PERCEPTIVE CREDIT HOLDINGS, LP
Reel/Frame 039707/0194 →
SECURITY AGREEMENT Recorded Dec 18, 2012
From: MONOSOL RX, LLC
To: WHITE OAK GLOBAL ADVISORS, LLC, AS AGENT
Reel/Frame 029490/0156 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2011
From: BOGUE, BEUFORD A.
To: MONOSOL RX, LLC
Reel/Frame 026116/0646 →
Continuity (1)
Related Publication 20120263865A1 · Oct 18, 2012